Literature DB >> 10838600

Schizophrenia, the dopamine hypothesis and alpha2-adrenoceptor antagonists.

L H Lindström1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10838600     DOI： 10.1016/s0165-6147(00)01474-7

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  3 in total

1.  alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.

Authors:  V Fagerholm; M Scheinin; M Haaparanta
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

2.  Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

Authors:  Charlotte Wiker; Love Linnér; Marie-Louise Wadenberg; Torgny H Svensson
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

3.  Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

Authors:  Charlotte Wiker; Love Linnér; Marie-Louise Wadenberg; Torgny H Svensson
Journal:  Neuropsychiatr Dis Treat       Date:  2005-09       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.